Round Type
Series A
SeoulBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Innovative biotechnology company specializing in new drug discovery and development, Avelos Therapeutics, has received a glowing endorsement from the venture capital community by raising $8 million in the startup's Series A funding round. The funding will support the company's targeted, biomarker-driven onco-therapeutics that aim to target cancerous cells that have long been deemed "undruggable," using the concept of synthetic lethality. Financing was provided by several well-known venture capital firms, including SV Investment, UTC Investment, Quad Investment Management, Timepolio Asset Management, Mirae Asset Venture Investment and Mirae Asset Capital.
Quick answer
Avelos Therapeutics raised an undisclosed amount in a Series A round, dated August 22, 2022. Avelos Therapeutics is based in Seoul, Seoul, South Korea.
- How much did Avelos Therapeutics raise?
- Avelos Therapeutics raised an undisclosed amount in a Series A round on August 22, 2022.
- What does Avelos Therapeutics do?
- Avelos Therapeutics is a specialized research and development (R&D) company focused on oncology drug discovery and development working with small molecule drugs for undruggable targets in the synthetic lethality, DNA..
- Where is Avelos Therapeutics based and how big is it?
- Avelos Therapeutics is based in Seoul, Seoul, South Korea.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Avelos Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Qnovia raised $17M (Series A) on September 28, 2022.
- Damona Pharmaceuticals raised $5.5M (Seed) on September 28, 2022.
- Damona Pharmaceuticals raised $5.5M (Seed) on September 26, 2022.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
Who to call at Avelos Therapeutics, and when
A new round usually means Avelos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avelos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avelos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avelos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avelos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAvelos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.